00027 PE Ratio & Valuation,Is 00027 Overvalued — Intellectia
00027 Relative Valuation
00027's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 00027 is overvalued; if below, it's undervalued.
Historical Valuation
GALAXY ENT(00027) is now in theFairzone, suggesting that its currentforward PSratio of0.00is consideredFairlycompared with the five-year average of37.61.The fair price ofGALAXY ENT(00027)is betweenNaNtoNaNaccording to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：37.72
Fair
14.58
PE
1Y
3Y
5Y
Trailing
Forward
10.14
EV/EBITDA
GALAXY ENT. (00027) has a current EV/EBITDA of 10.14. The 5-year average EV/EBITDA is -2.38. The thresholds are as follows: Strongly Undervalued below -218.29, Undervalued between -218.29 and -110.33, Fairly Valued between 105.58 and -110.33, Overvalued between 105.58 and 213.53, and Strongly Overvalued above 213.53. The current Forward EV/EBITDA of 10.14 falls within the Historic Trend Line -Fairly Valued range.
14.03
EV/EBIT
GALAXY ENT. (00027) has a current EV/EBIT of 14.03. The 5-year average EV/EBIT is 5903.03. The thresholds are as follows: Strongly Undervalued below -45669.80, Undervalued between -45669.80 and -19883.39, Fairly Valued between 31689.44 and -19883.39, Overvalued between 31689.44 and 57475.86, and Strongly Overvalued above 57475.86. The current Forward EV/EBIT of 14.03 falls within the Historic Trend Line -Fairly Valued range.
3.31
PS
GALAXY ENT. (00027) has a current PS of 3.31. The 5-year average PS is 6.27. The thresholds are as follows: Strongly Undervalued below -0.80, Undervalued between -0.80 and 2.73, Fairly Valued between 9.80 and 2.73, Overvalued between 9.80 and 13.33, and Strongly Overvalued above 13.33. The current Forward PS of 3.31 falls within the Historic Trend Line -Fairly Valued range.
11.51
P/OCF
GALAXY ENT. (00027) has a current P/OCF of 11.51. The 5-year average P/OCF is 29.77. The thresholds are as follows: Strongly Undervalued below -102.68, Undervalued between -102.68 and -36.45, Fairly Valued between 96.00 and -36.45, Overvalued between 96.00 and 162.23, and Strongly Overvalued above 162.23. The current Forward P/OCF of 11.51 falls within the Historic Trend Line -Fairly Valued range.
24.31
P/FCF
GALAXY ENT. (00027) has a current P/FCF of 24.31. The 5-year average P/FCF is -1.89. The thresholds are as follows: Strongly Undervalued below -167.89, Undervalued between -167.89 and -84.89, Fairly Valued between 81.11 and -84.89, Overvalued between 81.11 and 164.10, and Strongly Overvalued above 164.10. The current Forward P/FCF of 24.31 falls within the Historic Trend Line -Fairly Valued range.
GALAXY ENT (00027) has a current Price-to-Book (P/B) ratio of 2.07. Compared to its 3-year average P/B ratio of 2.49 , the current P/B ratio is approximately -16.76% higher. Relative to its 5-year average P/B ratio of 2.80, the current P/B ratio is about -26.04% higher. GALAXY ENT (00027) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.80%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.08% , the current FCF yield is about -100.00% lower.
2.07
P/B
Median3y
2.49
Median5y
2.80
0.00
FCF Yield
Median3y
1.80
Median5y
-1.08
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 00027 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 00027 in the past 1 year is driven by Unknown.
Is GALAXY ENT (00027) currently overvalued or undervalued?
GALAXY ENT(00027)is now in theFairzone, suggesting that its currentforward PSratio of 0.00is consideredFairlycompared with the five-year average of37.61.The fair price of GALAXY ENT(00027)is betweenNaNtoNaNaccording to relative valuation methord.
What is GALAXY ENT (00027) fair value?
00027's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of GALAXY ENT (00027) is between NaNtoNaN according to relative valuation methord.
How does 00027's valuation metrics compare to the industry average?
The average P/S ratio for 00027's competitors is , providing a benchmark for relative valuation. GALAXY ENT Corp (00027) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for GALAXY ENT (00027) as of Dec 17 2025?
As of Dec 17 2025, GALAXY ENT (00027) has a P/B ratio of 2.07. This indicates that the market values 00027 at 2.07 times its book value.
What is the current FCF Yield for GALAXY ENT (00027) as of Dec 17 2025?
As of Dec 17 2025, GALAXY ENT (00027) has a FCF Yield of 0.00%. This means that for every dollar of GALAXY ENT’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for GALAXY ENT (00027) as of Dec 17 2025?
As of Dec 17 2025, GALAXY ENT (00027) has a Forward P/E ratio of 14.58. This means the market is willing to pay $14.58 for every dollar of GALAXY ENT’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for GALAXY ENT (00027) as of Dec 17 2025?
As of Dec 17 2025, GALAXY ENT (00027) has a Forward P/S ratio of 0.00. This means the market is valuing 00027 at $0.00 for every dollar of expected revenue over the next 12 months.
